Background illustration for clinical trials search

Paid Clinical Trials Billings

Discover 125 paid clinical trials in Billings, Montana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Billings MT, Pierre SD, Spokane WA, Lakewood CO,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase3, Recruiting

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

for
Ovarian Cancer
Location: Billings MT, Salt Lake City UT, Sioux Falls SD,
Sponsor: Daiichi Sankyo

Sex: Female

Age: 18+

Code: NCT06819007

Phase3, Recruiting
FeaturedActive & Responsive

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

for
Hypothyroidism
Location: Billings MT, Butte MT, Idaho Falls ID, Ogden UT,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06345339

Phase2, Phase3, Recruiting
New

Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure

for
Healthy Adult Participants
Location: Billings MT, Cheyenne WY, Salt Lake City UT, Boise ID,
Sponsor: Ecotera Health LLC

Sex: All

Age: 18+

Code: NCT07775495

Recruiting

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

for
Breast Cancer, Metastatic
Location: Billings MT, Golden CO, Denver CO, Grand Junction CO,
Sponsor: ALX Oncology Inc.

Sex: All

Age: 18+

Code: NCT07007559

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image